122 related articles for article (PubMed ID: 11125748)
1. The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women.
Alvarez-Arcaya A; Combarros O; Llorca J; Sánchez-Guerra M; Berciano J; Fernández-Viadero C; Peña N
Acta Neurol Scand; 2000 Dec; 102(6):350-3. PubMed ID: 11125748
[TBL] [Abstract][Full Text] [Related]
2. Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease.
Wiebusch H; Poirier J; Sévigny P; Schappert K
Hum Genet; 1999 Feb; 104(2):158-63. PubMed ID: 10190327
[TBL] [Abstract][Full Text] [Related]
3. No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
Ki CS; Na DL; Kim JW; Kim HJ; Kim DK; Yoon BK
Am J Med Genet; 1999 Apr; 88(2):113-5. PubMed ID: 10206226
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
[TBL] [Abstract][Full Text] [Related]
5. Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the epsilon4 allele of the apolipoprotein gene in Japanese patients with Alzheimer's disease.
Yamamoto Y; Yasuda M; Mori E; Maeda K
J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):94-6. PubMed ID: 10369830
[TBL] [Abstract][Full Text] [Related]
6. The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.
Kehoe PG; Williams H; Holmans P; Wilcock G; Cairns NJ; Neal J; Owen MJ
J Med Genet; 1998 Dec; 35(12):1034-5. PubMed ID: 9863603
[TBL] [Abstract][Full Text] [Related]
7. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
[TBL] [Abstract][Full Text] [Related]
9. Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland.
McIlroy SP; Crawford VL; Dynan KB; McGleenon BM; Vahidassr MD; Lawson JT; Passmore AP
J Med Genet; 2000 Mar; 37(3):182-5. PubMed ID: 10699053
[TBL] [Abstract][Full Text] [Related]
10. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.
Raygani AV; Zahrai M; Soltanzadeh A; Doosti M; Javadi E; Pourmotabbed T
Neurosci Lett; 2004 Nov; 371(2-3):142-6. PubMed ID: 15519745
[TBL] [Abstract][Full Text] [Related]
11. Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients.
Hiltunen M; Mannermaa A; Helisalmi S; Koivisto A; Lehtovirta M; Ryynänen M; Riekkinen P; Soininen H
Neurosci Lett; 1998 Jun; 250(1):69-71. PubMed ID: 9696068
[TBL] [Abstract][Full Text] [Related]
12. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease.
Lehmann DJ; Johnston C; Smith AD
Hum Mol Genet; 1997 Oct; 6(11):1933-6. PubMed ID: 9302273
[TBL] [Abstract][Full Text] [Related]
13. No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease.
Singleton AB; Smith G; Gibson AM; Woodward R; Perry RH; Ince PG; Edwardson JA; Morris CM
Hum Mol Genet; 1998 May; 7(5):937-9. PubMed ID: 9536100
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease.
Tilley L; Morgan K; Grainger J; Marsters P; Morgan L; Lowe J; Xuereb J; Wischik C; Harrington C; Kalsheker N
Eur J Hum Genet; 1999 Sep; 7(6):659-63. PubMed ID: 10482954
[TBL] [Abstract][Full Text] [Related]
15. The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations.
Crawford F; Fallin D; Suo Z; Abdullah L; Gold M; Gauntlett A; Duara R; Mullan M
Neurosci Lett; 1998 Jun; 249(2-3):115-8. PubMed ID: 9682830
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease.
Brindle N; Song Y; Rogaeva E; Premkumar S; Levesque G; Yu G; Ikeda M; Nishimura M; Paterson A; Sorbi S; Duara R; Farrer L; St George-Hyslop P
Hum Mol Genet; 1998 May; 7(5):933-5. PubMed ID: 9536099
[TBL] [Abstract][Full Text] [Related]
17. Neither the butyrylcholinesterase K variant nor transferrin C2 variant confers a risk for Alzheimer's disease in Koreans.
Kim KW; Jhoo JH; Lee JH; Lee KU; Lee DY; Youn JC; Youn JY; Woo JI
J Neural Transm (Vienna); 2001; 108(10):1159-66. PubMed ID: 11725818
[TBL] [Abstract][Full Text] [Related]
18. Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease.
Yoo HB; Lee HW; Shin S; Park SW; Choi JS; Jung HY; Cha J; Lee JM; Lee JY
Curr Alzheimer Res; 2014 Feb; 11(2):137-44. PubMed ID: 24479631
[TBL] [Abstract][Full Text] [Related]
19. Butyrylcholinesterase K variant and Alzheimer's disease risk: a meta-analysis.
Wang Z; Jiang Y; Wang X; Du Y; Xiao D; Deng Y; Wang J
Med Sci Monit; 2015 May; 21():1408-13. PubMed ID: 25978873
[TBL] [Abstract][Full Text] [Related]
20. Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.
Gabriel AJ; Almeida MR; Ribeiro MH; Durães J; Tábuas-Pereira M; Pinheiro AC; Pascoal R; Santana I; Baldeiras I
Neurosci Lett; 2017 Feb; 641():101-106. PubMed ID: 28108398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
